Results 61 to 70 of about 4,185 (125)
Cytokines and cytotoxicity: Dissecting susceptibility to lethal hyperinflammation
Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS) are life-threatening hyperinflammatory syndromes. Familial HLH is caused by genetic impairment of granule-mediated cytotoxicity (e.g., perforin-deficiency).
Landy, Emily
core
This publication explores Protein kinase D inhibition in the context of physical trauma as a way to regulate neutrophil infiltration as well as to dampen post-traumatic hyperinflammation.
Schönfelder, Jonathan
core +1 more source
Immunomodulatory Drugs in the Management of SARS-CoV-2
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders ...
Daniel R. Burrage +4 more
doaj +1 more source
ECMO in Cardiogenic Shock: Time Course of Blood Biomarkers and Associated Mortality
Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a temporary life support for severe cardiogenic shock, gaining time for organ recovery, permanent assistance, or transplantation.
Sasa Rajsic +3 more
doaj +1 more source
Abstract Haploinsufficiency of A20 (HA20) is a rare autoinflammatory disorder caused by heterozygous loss‐of‐function variants in tumor necrosis factor alpha‐induced protein 3 (TNFAIP3), encoding a negative regulator of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NFκB) signaling.
Amanda Blake +5 more
wiley +1 more source
The treatment with Jusvinza reduces hyperinflammation and hypercoagulation in critical ill patients with COVID-19 [PDF]
Introduction: Infection with SARS-CoV-2 induces a prothrombotic state in patients, by the combination of hyperinflammatory response and hypoxia. In Cuba, the drug called Jusvinza, based on an immunomodulatory peptide, is used for the treatment of ...
Leticia Rosario Cruz +13 more
core
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series [PDF]
Objectives Anakinra is a selective IL-1 inhibitor, which has been used in the context of secondary haemophagocytic lymphohistiocytosis. Although usually given in the s.c. form, previous anecdotal reports have emphasized its utility when given i.v.
Singh, A +5 more
core +1 more source
Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley +1 more source
Human papillomaviruses (HPVs) have evoked numerous mechanisms to subvert host innate immunity and establish a local immunosuppressive environment to facilitate persistent virus infection.
Frazer I.H. (3632404) +3 more
core +1 more source
MOFs offer high porosity and tunability for biomedical applications, especially in cancer therapy via ROS generation and targeted delivery. Though toxicity, stability, and scalability remain key clinical challenges. Drug loading in MOFs exceeds 60%–70% with controlled release behavior.
Jagabandhu Bag +6 more
wiley +1 more source

